PASITHEA THERAPEUTICS CORP. Proceeds from Notes Payable
PASITHEA THERAPEUTICS CORP. (KTTA) reported Proceeds from Notes Payable of $379.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2025-11-13
- PASITHEA THERAPEUTICS CORP. proceeds from notes payable for the quarter ending 2025-09-30 was $0.00.
- PASITHEA THERAPEUTICS CORP. proceeds from notes payable for the quarter ending 2025-06-30 was $0.00.
- PASITHEA THERAPEUTICS CORP. proceeds from notes payable for the quarter ending 2025-03-31 was $379.00K.
- PASITHEA THERAPEUTICS CORP. proceeds from notes payable for the quarter ending 2023-12-31 was $0.00.
- PASITHEA THERAPEUTICS CORP. proceeds from notes payable for fiscal 2023 was $392.35K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $379.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $379.00K 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $379.00K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $0.00 derived: sum of 2 quarters · filed 2025-03-24 | $0.00 derived: sum of 3 quarters · filed 2025-03-24 | $392.35K 10-K · filed 2025-03-24 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $392.35K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $392.35K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $392.35K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |